Literature DB >> 19455596

Unstable familial transmissions of Huntington disease alleles with 27-35 CAG repeats (intermediate alleles).

A Semaka1, J A Collins, M R Hayden.   

Abstract

There are inconsistent reports regarding the likelihood of repeat instability for alleles with 27-35 CAG repeats in the Huntington disease (HD) gene. We have examined the intergenerational stability of such intermediate alleles in 51 families from the University of British Columbia's DNA and Tissue Bank for Huntington Disease Research (UBC-HD Databank). A total of 181 transmissions were identified, with 30% (n = 54/181) of the alleles being unstable upon transmission. The unstable transmissions included both expansions (n = 37) and contractions (n = 17) of CAG size. Of the expanded alleles, 68% (n = 25/37) expanded into the HD range (>36 CAG). Therefore, 14% (n = 25/181) of the 27-35 CAG allele transmissions examined expanded into the disease-associated range resulting in a new mutation for HD. Significantly, of these new mutations, 40% (n = 10/25) originated from an allele with 35 CAG repeats with CAG repeat expansions ranging from +1 CAG to +23 CAG. The proportion of new mutations in the UBC-HD Databank is consistent with the most recent new mutation rate for HD, estimated to be at least 10%. The observed difference in the stability of HD intermediate allele transmissions in this data set and in other studies may be a reflection of a small sample size. Alternately, these inconsistencies may indicate an underlying difference in genetic factors which influence repeat instability between the different populations examined. Additional studies determining the frequency and magnitude of repeat instability in this CAG repeat range and factors that influence instability are urgently needed. Until we understand the clinical implications of HD alleles with 27-35 CAG repeats and establish reliable risks of instability, we should exercise caution when translating these results to the clinic. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 19455596     DOI: 10.1002/ajmg.b.30970

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  14 in total

Review 1.  Therapy in Huntington's disease: where are we?

Authors:  Martha A Nance
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

2.  De novo Huntington disease caused by 26-44 CAG repeat expansion on a low-risk haplotype.

Authors:  Gunnar Houge; Ove Bruland; Inga Bjørnevoll; Michael R Hayden; Alicia Semaka
Journal:  Neurology       Date:  2013-08-14       Impact factor: 9.910

3.  Response to Falush: a role for cis-element polymorphisms in HD.

Authors:  Simon C Warby; Henk Visscher; Stefanie Butland; Christopher E Pearson; Michael R Hayden
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

4.  Full sequence of mutant huntingtin 3'-untranslated region and modulation of its gene regulatory activity by endogenous microRNA.

Authors:  Kyung-Hee Kim; Kawther Abu Elneel; Jun Wan Shin; Jae Whan Keum; David Seong; Seung Kwak; Ramee Lee; James F Gusella; Marcy E MacDonald; Ihn Sik Seong; Jong-Min Lee
Journal:  J Hum Genet       Date:  2019-07-11       Impact factor: 3.172

5.  Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease.

Authors:  Galen E B Wright; Jennifer A Collins; Chris Kay; Cassandra McDonald; Egor Dolzhenko; Qingwen Xia; Kristina Bečanović; Britt I Drögemöller; Alicia Semaka; Charlotte M Nguyen; Brett Trost; Fiona Richards; Emilia K Bijlsma; Ferdinando Squitieri; Colin J D Ross; Stephen W Scherer; Michael A Eberle; Ryan K C Yuen; Michael R Hayden
Journal:  Am J Hum Genet       Date:  2019-05-16       Impact factor: 11.025

6.  Huntington disease: who seeks presymptomatic genetic testing, why and what are the outcomes?

Authors:  Tracey M Scuffham; John C MacMillan
Journal:  J Genet Couns       Date:  2014-01-08       Impact factor: 2.537

Review 7.  Genetics and neuropathology of Huntington's disease.

Authors:  Anton Reiner; Ioannis Dragatsis; Paula Dietrich
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

8.  Parental repeat length instability in myotonic dystrophy type 1 pre- and protomutations.

Authors:  Isis B T Joosten; Debby M E I Hellebrekers; Bianca T A de Greef; Hubert J M Smeets; Christine E M de Die-Smulders; Catharina G Faber; Monique M Gerrits
Journal:  Eur J Hum Genet       Date:  2020-03-12       Impact factor: 4.246

Review 9.  A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases.

Authors:  Jane S Paulsen; Martha Nance; Ji-In Kim; Noelle E Carlozzi; Peter K Panegyres; Cheryl Erwin; Anita Goh; Elizabeth McCusker; Janet K Williams
Journal:  Prog Neurobiol       Date:  2013-09-11       Impact factor: 11.685

10.  Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes.

Authors:  Fiona K Baine; Chris Kay; Maria E Ketelaar; Jennifer A Collins; Alicia Semaka; Crystal N Doty; Amanda Krause; L Jacquie Greenberg; Michael R Hayden
Journal:  Eur J Hum Genet       Date:  2013-03-06       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.